Key facts
- It has raised $31.0M; the latest was Later Stage VC ($23.7M) in Feb 2026.
- Notable investors include Creative Destruction Lab, MassMutual Ventures, Crane Venture Partners, Wellington Partners, Armira Beteiligungen — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for nyra health
- ·The full record, as it builds
Funding rounds
No funding rounds for nyra health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About nyra health
Developer of a digital neurotherapy platform designed to support speech, language, cognitive, and everyday skill rehabilitation for people with neurological conditions. The company's platform offers personalized therapy programs, evidence-based exercises, insurance-supported access, and clinical management tools, enabling patients, clinics, and therapy practices to deliver consistent rehabilitation and support long-term recovery.
- Sector
- Healthcare
- HQ
- Vienna, Austria
- Founded
- 2020
- Employees
- 37
- Website
- nyra.health/
- Ownership
- Privately Held (backing)
nyra health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in nyra health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on nyra health in its N-PORT filings yet. We sweep new filings monthly.